Michael Ellis
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 33
- Tuberculosis Research and Epidemiology 5
- Epidemiology top 1%
- Fungal Infections and Studies 19
- Pneumocystis jirovecii pneumonia detection and treatment 11
- Mycobacterium research and diagnosis 8
- Infective Endocarditis Diagnosis and Management 5
- Oncology top 5%
- Neutropenia and Cancer Infections 20
- Microbiology top 5%
- Small Animals top 2%
-
- Bacterial Identification and Susceptibility Testing 5
- Co-authors
- William GreerHail M. Al-AbdelyW.P. VenturaAmy L. SandridgeBasel K. al-RamadiDavid W. DenningDavid J. SpenceJörgen Kristensen
- Journals
- Journal of Medical Microbiology (6 papers)Journal of Infection (5 papers)Clinical Infectious Diseases (4 papers)
- Partner nations
- Saudi ArabiaUnited Arab EmiratesUnited Kingdom
In The Last Decade
Michael Ellis
101 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 130
- Infectious Diseases 1.7k
- Epidemiology 1.7k
- Oncology 680
- Microbiology 18
- Small Animals 171
Countries citing papers authored by Michael Ellis
This map shows the geographic impact of Michael Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ellis more than expected).
Fields of papers citing papers by Michael Ellis
This network shows the impact of papers produced by Michael Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ellis. The network helps show where Michael Ellis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2015 | 26 | |
| 3 | 2011 | 19 | |
| 4 | 2008 | 22 | |
| 5 | 2006 | 17 | |
| 6 | 2004 | 28 | |
| 7 | 2001 | 336 | |
| 8 | 1998 | 183 | |
| 9 | 1998 | 206 | |
| 10 | 1997 | 5 | |
| 11 | 1997 | 32 | |
| 12 | 1994 | 83 | |
| 13 | HIV INFECTION IN SAUDI ARABIA: OCCURRENCE PATTERN OF DISEASE AND FUTURE IMPLICATIONS | 1993 | 8 |
| 14 | Beta-lactamase Production in Recent Clinical Isolates of Haemophilus influezai and their Susceptibility to Cefaclor and Other Antimicrobial Agents | 1993 | 4 |
| 15 | 1993 | 19 | |
| 16 | 1993 | 7 | |
| 17 | 1991 | 5 | |
| 18 | 1990 | 3 | |
| 19 | 1989 | 1 | |
| 20 | 1984 | 28 |
About Michael Ellis
Michael Ellis is a scholar working on Infectious Diseases, Epidemiology, Oncology, Clinical Biochemistry and Process Chemistry and Technology, having authored 104 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (33 papers), Neutropenia and Cancer Infections (20 papers), Fungal Infections and Studies (19 papers), Pneumocystis jirovecii pneumonia detection and treatment (11 papers), Mycobacterium research and diagnosis (8 papers), Tuberculosis Research and Epidemiology (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Infective Endocarditis Diagnosis and Management (5 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Epidemiology (1.7k citations), Oncology (680 citations), Microbiology (18 citations) and Small Animals (171 citations). Michael Ellis has collaborated with scholars based in Saudi Arabia, United Arab Emirates and United Kingdom. Frequent co-authors include William Greer, Hail M. Al-Abdely, W.P. Ventura, Amy L. Sandridge, Basel K. al-Ramadi, David W. Denning, David J. Spence, Jörgen Kristensen, Hussain Alizadeh and Anders Hauggaard. Their work appears in journals such as Journal of Medical Microbiology, Journal of Infection, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Archives of Disease in Childhood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.